search

Journal of the Royal Statistical Society Series C: Applied Statistics, Volume 73, Issue 2, March 2024, Pages 444–459, https://doi.org/10.1093/jrsssc/qlad103

Published: 17 November 2023

Supplementary data

Journal Article

CSIG-08. GAIN-OF-FUNCTION MUTANT P53 REGULATES LONG-NONCODING RNAS TO CONTROL HIF1Α TRANSCRIPTION IN GLIOBLASTOMA

PDF

Ying Zhang and others

in Neuro-Oncology

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v41, https://doi.org/10.1093/neuonc/noad179.0164

Published: 10 November 2023

Journal Article

CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

PDF

Nazanin Majd and others

in Neuro-Oncology

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v84, https://doi.org/10.1093/neuonc/noad179.0324

Published: 10 November 2023

Journal Article

SAM: Self-Adapting Mixture Prior to Dynamically Borrow Information from Historical Data in Clinical Trials

PDF

Peng Yang and others

in Biometrics

Biometrics, Volume 79, Issue 4, December 2023, Pages 2857–2868, https://doi.org/10.1111/biom.13927

Published: 18 September 2023

Supplementary data

Journal Article

Seamless phase II/III design: a useful strategy to reduce the sample size for dose optimization

PDF

Liyun Jiang and Ying Yuan

in JNCI: Journal of the National Cancer Institute

JNCI: Journal of the National Cancer Institute, Volume 115, Issue 9, September 2023, Pages 1092–1098, https://doi.org/10.1093/jnci/djad103

Published: 27 May 2023

Supplementary data

Journal Article

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

PDF

Timothy A Gregory and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad032, https://doi.org/10.1093/noajnl/vdad032

Published: 13 April 2023

Supplementary data

Journal Article

Duality of immune recognition by tomato and virulence activity of the Ralstonia solanacearum exo-polygalacturonase PehC

PDF

Jingjing Ke and others

in The Plant Cell

The Plant Cell, Volume 35, Issue 7, July 2023, Pages 2552–2569, https://doi.org/10.1093/plcell/koad098

Published: 29 March 2023

Supplementary data

Journal Article

DROID: Dose-Ranging Approach to Optimizing Dose in Oncology Drug Development

PDF

Beibei Guo and Ying Yuan

in Biometrics

Biometrics, Volume 79, Issue 4, December 2023, Pages 2907–2919, https://doi.org/10.1111/biom.13840

Published: 20 February 2023

Supplementary data

2 3 4 5

Modify your search

Availability

NARROW

Format

Subject

Type

Collection

Journal

Publication date

A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825 Get access

CTNI-46. WINDOW-OF-OPPORTUNITY TRIAL OF ULIXERTINIB FOR MAPK-ACTIVATED LOWER GRADE GLIOMAS IN ADULTS

DNAR-10. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

CTIM-03. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT

NINJ1-mediated macrophage plasma membrane rupture and neutrophil extracellular trap formation contribute to oxalate nephropathy Get access

ROMI: a randomized two-stage basket trial design to optimize doses for multiple indications Get access

A Bayesian pharmacokinetics integrated phase I–II design to optimize dose-schedule regimes Get access

A Bayesian latent-subgroup platform design for dose optimization Get access

A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia Get access

A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice

A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison

Adaptive hybrid control design for comparative clinical trials with historical control data

CSIG-08. GAIN-OF-FUNCTION MUTANT P53 REGULATES LONG-NONCODING RNAS TO CONTROL HIF1Α TRANSCRIPTION IN GLIOBLASTOMA

CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

SAM: Self-Adapting Mixture Prior to Dynamically Borrow Information from Historical Data in Clinical Trials

Seamless phase II/III design: a useful strategy to reduce the sample size for dose optimization

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

Duality of immune recognition by tomato and virulence activity of the Ralstonia solanacearum exo-polygalacturonase PehC

DROID: Dose-Ranging Approach to Optimizing Dose in Oncology Drug Development

Modify your search

Publication date

This Feature Is Available To Subscribers Only